Additional insights from the 2023 Global Leukemia Experience Survey: CLL specific findings, unmet needs and recommendations for action – Now published on the CLLAN Website!

We are pleased to share additional insights from the “2023 Global Leukemia Experience Survey: CLL specific findings, unmet needs and recommendations for action“.

The Chronic Lymphocytic Leukaemia Advocates Network (CLLAN) conducted an analysis of the 2023 Global Leukemia Experience Survey data to examine diagnostic pathways, immunity status, and treatment decision experiences of people with CLL. The survey was a collaboration between Acute Leukemia Advocates Network (ALAN), CML Advocates Network (CMLAN) and CLLAN. It was released online in 13 languages to international respondents aged 18 or more, distributed via the advocacy networks.

It is well known that each diagnoses within the broader leukaemia classification face a varied diagnostic and treatment pathway, and ultimately for individuals, different challenges to navigate. We provide the key findings and implications for people with CLL, and outline the key findings and recommendations for clinicians and advocacy groups.

To access “2023 Global Leukemia Experience Survey: CLL specific findings, unmet needs and recommendations for action” CLICK HERE.

To access Full “Global Leukemia Experience Survey 2023 Report” CLICK HERE.

We wish to thank all those individuals that took the time to complete survey. This report is YOURS! Thank you for contributing to this important piece of evidence!